Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
Learn more about our COVID-19 testing.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
*Data current as of 4/1/22
molecular tests performed
COVID-19 testing platforms implemented
serology tests performed
support from Mayo Clinic physicians and scientists
Mayo Clinic Laboratories provides testing and associated support for our clients around the world as they manage the ongoing effects of COVID-19. We offer a comprehensive menu of COVID-19 and related testing, including molecular (PCR) testing to diagnose active COVID-19 infection; serology testing to identify people who previously had COVID-19 or have active immunity; and COVID-19/influenza multiplex testing.
Mayo Clinic researchers and experts have played a key role in the global response to COVID-19 — from developing and deploying testing, to providing up-to-date information to the public, to advising government and businesses on the best ways to keep people safe.
Featuring Mayo Clinic Laboratories in the news, as well as the latest COVID-19 podcasts and articles. Keep up to date on testing developments and scientific advances.
COVID-19 focused podcasts
Mayo Clinic experts share their knowledge on the state of testing, vaccines, treatments, and more. Podcasts are hosted by Bobbi Pritt, M.D., chair of Mayo Clinic's Division of Clinical Microbiology.
Access COVID-19 resources, reference guides, educational content, FAQs, and more.
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.
PACE - In this month’s “Virtual Lecture,” William Morice, M.D., Ph.D., gives an overview of the national response to the need for COVID-19 testing at the onset of, and during, the pandemic.
Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.
Dr. Morice talks about what lies ahead for laboratory medicine and how the opportunities and challenges in the field are intertwined.
Topics include: Community leaders are key to reaching people underrepresented in research.